Danaher Corporation is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands has leadership positions in the demanding and attractive health care, environmental and applied end-markets. With more than 20 operating companies, Danaher's globally diverse team of approximately 69,000 associates is united by a common culture and operating system, the Danaher Business System, and its Shared Purpose, Helping Realize Life's Potential.
2200 Pennsylvania Ave NW Ste 800W
Washington, Washington Dc 20037-1731
Phone: 12028280850
www.danaher.com
Danaher ($DHR) is an American global conglomerate with a strong presence in the life sciences and diagnostics industries. It’s an under-the-radar c…
Insider Sale: Senior Vice President - General Counsel Brian Ellis Sells 9,600 Shares of Danaher Corp (DHR)
On CNBC''s “ Halftime Report Final Trades ,” Bryn Talkington of Requisite Capital Management named Freeport-McMoRan Inc . (NYSE: FCX ) as her final trade . On July 23, Freeport-McMoRan said second-quarter revenue came in at $6.62 billion, beating the consensus of $5.99 billion. Adjusted EPS was 46 cents, beating the consensus of 38 cents. The company also announced a $7.5 billion expansion of its El Abra copper mine in northern Chile. Freshly-appointed CEO Kathleen Quirk made this announcement during an earnings call. Don''t forget … Full story available on Benzinga.com
https://www.investing.com/news/company-news/danaher-corp-reaches-52week-high-hitting-27313-93CH-3536614
https://www.investing.com/news/company-news/td-cowen-raises-danaher-stock-price-target-on-strong-performance-93CH-3534469
This quarter was exactly what we needed to see from the life sciences company.
Danaher Corporation beat analysts'' expectations on the top and bottom lines with its second-quarter results, sending shares higher in intraday trading Tuesday.
The biotechnology, diagnostics, and life sciences company looks set to return to its long-term growth rate.
Danaher (NYSE: DHR ) just reported results for the second quarter of 2024. Danaher reported earnings per share of $1.72. This was above the analyst estimate for EPS of $1.57. The company reported revenue of $5.74 billion. This was 2.74% better than the analyst estimate for revenue of $5.59 billion. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at [email protected]. More From InvestorPlace Legendary Investor Predicts: “Forget AI… THIS Technology Is the Future” The post DHR Stock Earnings: Danaher Beats EPS, Beats Revenue for Q2 2024 appeared first on InvestorPlace .
